Compare UBC Medical Indonesia Tbk. (LABS) vs Putra Mandiri Jembar Tbk. (PMJS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp143 (market cap 2.01T, 1.63M 24h volume). The key difference: Putra Mandiri Jembar Tbk. is far larger — about 2.9× UBC Medical Indonesia Tbk.'s market cap, and Putra Mandiri Jembar Tbk. is more actively traded (1.63M versus 635.5K). Which is the better fit depends on your goals.
| LABS | PMJS | |
|---|---|---|
Market Cap | 691.25B | 2.01T |
Volume | 635.5K | 1.63M |
Lot | 6.36K | 16.34K |
Turnover | 110.15M | 235.47M |
Average Price | 173.33 | 144.09 |
Value | 110.15M | 235.47M |
Indicative Equilibrium Price | 174 | 143 |
Indicative Equilibrium Volume | 50 | 678 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Putra Mandiri Jembar Tbk.
PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →
